Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older
NCT ID: NCT04526314
Last Updated: 2020-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
308 participants
OBSERVATIONAL
2018-01-01
2020-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Life and Care of Colorectal Cancer Patients After 65 Years and Their Family
NCT04458740
The Life and Care of Patients With Colorectal Cancer Before Age 65 and Their Kindred
NCT04451343
Prognostic Value of the Lymphocytic Infiltrate in Colon Cancers
NCT02557061
Personalized Medicine in Early Stage Colorectal Cancer: Organ Preservation and Immune Benefit
NCT06251726
Evaluation of Some Risk Factors Associated With Colorectal Cancer
NCT05170360
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stage 3 with adjuvant chemotherapy
observational
observational
Stage 3 without adjuvant chemotherapy
observational
observational
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observational
observational
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients receiving neo-adjuvant chemotherapy or radiotherapy
* Tumours of the appendix
* Tumours with histology other than adenocarcinoma
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Registre des Tumeurs Digestives du Finistère
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michel Robaskiewicz, MD PhD
Role: STUDY_CHAIR
REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Registre de tumeurs digestives du Finistère
Brest, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Badic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Queneherve L. Prognostic factors for stage III colon cancer in patients 80 years of age and older. Int J Colorectal Dis. 2021 Apr;36(4):811-819. doi: 10.1007/s00384-021-03861-6. Epub 2021 Feb 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
908270
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.